It is important for asymptomatic CF carriers with specific mutations to be monitored long-term as studies show that CF carriers exhibit slight CFTR dysfunction and are at risk of CRD and, therefore, chronic pancreatitis in heterozygous carriers [20]. The gene discussed is CFTR; the disease is chronic pancreatitis.